SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-18-000068
Filing Date
2018-08-09
Accepted
2018-08-09 16:06:13
Documents
64
Period of Report
2018-06-29

Document Format Files

Seq Description Document Type Size
1 10-Q opnt063201810q.htm 10-Q 769988
2 EXHIBIT 31.1 exhibit3110632018.htm EX-31.1 12651
3 EXHIBIT 31.2 exhibit3120632018.htm EX-31.2 12630
4 EXHIBIT 32.1 exhibit3210632018.htm EX-32.1 5808
5 EXHIBIT 32.2 exhibit3220632018.htm EX-32.2 5570
  Complete submission text file 0001385508-18-000068.txt   4806517

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opnt-20180629.xml EX-101.INS 785241
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20180629.xsd EX-101.SCH 54136
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20180629_cal.xml EX-101.CAL 47592
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20180629_def.xml EX-101.DEF 275419
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20180629_lab.xml EX-101.LAB 588788
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20180629_pre.xml EX-101.PRE 385458
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 181005036
SIC: 1000 Metal Mining